Indicated for: cytomegalovirus infection
Route of administration: infusion
Substance: ganciclovir (antiviral)
ATC: J05AB06 (Antiinfectives for systemic use | Direct acting antivirals | Nucleosides and nucleotides excl. reverse transcriptase inhibitors)
Dose adjustment may be needed in kidney disease.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Ganciclovir is an antiviral medication used for the treatment and prevention of cytomegalovirus (CMV) infections in immunocompromised patients, such as those with HIV/AIDS or transplant recipients. It works by inhibiting viral DNA replication.
The medication is available as an injectable solution or oral capsules, and treatment must be administered under the supervision of a specialist. Ganciclovir is effective in reducing viral load and preventing severe complications.
Common side effects include nausea, diarrhea, decreased white blood cell count, and fatigue. It is important for patients to be monitored to prevent hematologic toxicity.
Ganciclovir is an essential therapeutic option for patients with severe CMV infections, helping to improve their prognosis.